Vanguard Group Inc A Tyr Pharma Inc Put Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LIFE
# of Institutions
59Shares Held
33.5MCall Options Held
7.5KPut Options Held
3.2K-
Federated Hermes, Inc. Pittsburgh, PA10.2MShares$14.8 Million0.05% of portfolio
-
Logos Global Management LP San Francisco, CA3.1MShares$4.53 Million0.56% of portfolio
-
Tikvah Management LLC Charlotte, NC2.46MShares$3.59 Million1.51% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.9MShares$2.78 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA1.68MShares$2.45 Million0.03% of portfolio
About aTYR PHARMA INC
- Ticker LIFE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,625,000
- Market Cap $41.8M
- Description
- aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...